Gene · 962
Papers3,378
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
1,201 to 1,220 of 3,378
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Knockdown of DIAPH3 Inhibits the Proliferation of Cervical Cancer Cells through Inactivating mTOR Signaling Pathway. | J Oncol | 2021 | 34659408 | PubTator, text mining | PubMed |
| Latest Progresses in Allergic Diseases Biomarkers: Asthma and Atopic Dermatitis. | Front Pharmacol | 2021 | 34658882 | PubTator, text mining | PubMed |
| Dried blood sample analysis by antibody array across the total testing process. | Sci Rep | 2021 | 34654894 | PubTator, text mining | PubMed |
| Pan-cancer analysis of the prognostic and immunological role of PSMB8. | Sci Rep | 2021 | 34650125 | PubTator, text mining | PubMed |
| Extra-cellular vesicles of the male genital tract: new actors in male fertility? | Basic Clin Androl | 2021 | 34645388 | PubTator, text mining | PubMed |
| DEN-Induced Rat Model Reproduces Key Features of Human Hepatocellular Carcinoma. | Cancers (Basel) | 2021 | 34638465 | PubTator, text mining | PubMed |
| Treatment Strategy for Multiple Myeloma to Improve Immunological Environment and Maintain MRD Negativity. | Cancers (Basel) | 2021 | 34638353 | PubTator, text mining | PubMed |
| Cancer Stem Cell for Tumor Therapy. | Cancers (Basel) | 2021 | 34638298 | PubTator, text mining | PubMed |
| Keeping Myeloma in Check: The Past, Present and Future of Immunotherapy in Multiple Myeloma. | Cancers (Basel) | 2021 | 34638271 | PubTator, text mining | PubMed |
| A Comprehensive Prognostic and Immunological Analysis of a Six-Gene Signature Associated With Glycolysis and Immune Response in Uveal Melanoma. | Front Immunol | 2021 | 34630418 | PubTator, text mining | PubMed |
| Association of lymphocyte subsets with mortality in severe COVID-19 pneumonia patients. | J Clin Lab Anal | 2021 | 34626490 | PubTator, text mining | PubMed |
| Development of a Toll-Like Receptor-Based Gene Signature That Can Predict Prognosis, Tumor Microenvironment, and Chemotherapy Response for Hepatocellular Carcinoma. | Front Mol Biosci | 2021 | 34621787 | PubTator, text mining | PubMed |
An Integrative Pan-Cancer Analysis of the Prognostic and Immunological Role of Casein Kinase 2 Alpha Protein 1 (CSNK2A1) in Human Cancers: A Study Based on Bioinformatics and Immunohistochemical Analysis. | Int J Gen Med | 2021 | 34621130 | PubTator, text mining | PubMed |
| High FODMAP diet causes barrier loss via lipopolysaccharide-mediated mast cell activation. | JCI Insight | 2021 | 34618688 | PubTator, text mining | PubMed |
| A novel prognostic signature based on immune-related genes of diffuse large B-cell lymphoma. | Aging (Albany NY) | 2021 | 34610582 | PubTator, text mining | PubMed |
| Determining the immune environment of cutaneous T-cell lymphoma lesions through the assessment of lesional blood drops. | Sci Rep | 2021 | 34608214 | PubTator, text mining | PubMed |
| Recognition of Tumor-Associated Antigens and Immune Subtypes in Glioma for mRNA Vaccine Development. | Front Immunol | 2021 | 34603319 | PubTator, text mining | PubMed |
| Global Pattern of CD8+ T-Cell Infiltration and Exhaustion in Colorectal Cancer Predicts Cancer Immunotherapy Response. | Front Pharmacol | 2021 | 34594218 | PubTator, text mining | PubMed |
| Molecular Characteristics, Clinical Implication, and Cancer Immunity Interactions of Pyroptosis-Related Genes in Breast Cancer. | Front Med (Lausanne) | 2021 | 34589498 | PubTator, text mining | PubMed |
| Microbiota of Breast Tissue and Its Potential Association with Regional Recurrence of Breast Cancer in Korean Women. | J Microbiol Biotechnol | 2021 | 34584037 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/962/papers?page=61